alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › control

control

7 studies tagged control, dated 2010-12-16 to 2020-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls 2020-01-01
  2. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls 2019-11-18
  3. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches 2019-09-01

Studies

7 studies carry this tag.

Date range

2010 to 2020

Top journals

  • Journal of Alzheimer's disease : JAD 2
  • CNS & neurological disorders drug targets 1
  • Clinical chemistry and laboratory medicine 1
  • Journal of neural transmission (Vienna, Austria : 1996) 1
  • Movement disorders : official journal of the Movement Disorder Society 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Journal of Alzheimer's disease : JAD 2020-01-01 Biomarkers

    In this sample, the high-throughput blood Aβ assay was not able to distinguish well between AD patients and controls.

  2. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Movement disorders : official journal of the Movement Disorder Society 2019-11-18 Biomarkers

    CSF neurofilament contributes to a panel of CSF α-synuclein species in differentiating PD patients from healthy controls.

  3. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Clinical chemistry and laboratory medicine 2019-09-01 Biomarkers

    Serum levels also correlated strongly with CSF levels for Simoa-based measurements (both ϱ = 0.62).

  4. The dynamic mechanism of presenilin-1 function: Sensitive gate dynamics and loop unplugging control protein access

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of disease 2016-02-04 Biomarkers

    There is no molecular explanation for the many presenilin 1 (PSEN1) mutations causing Alzheimer's disease, but both gain of function relating to amyloid production and loss of isolated PSEN1 function have been implied.

  5. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. CNS & neurological disorders drug targets 2014-01-01 Biomarkers

    Pre-treatment with co-ultraPEALut significantly reduced inducible nitric oxide synthase and glial fibrillary acidic protein expression, restored neuronal nitric oxide synthase and brainderived neurotrophic factor and reduced the apoptosis.

  6. Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2012-01-01 Biomarkers

    Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly correlated with the accumulation of amyloid-β (Aβ) peptides (mainly Aβ(1-42)).

  7. Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of neural transmission (Vienna, Austria : 1996) 2010-12-16 Biomarkers

    Cerebrospinal fluid (CSF) biomarkers, such as Aβ(42), total-tau and phosphorylated-tau(181) reflect neuropathological changes of Alzheimer's disease (AD).

All topic tags with their study counts